Cresco Labs (CRLBF) Expected to Announce Quarterly Earnings on Thursday

Cresco Labs (OTCMKTS:CRLBF) is projected to release its results before the market opens on Thursday, August 6th. Analysts expect Cresco Labs to announce earnings of ($0.02) per share and revenue of $166.1970 million for the quarter.

Cresco Labs (OTCMKTS:CRLBF) last released its quarterly earnings results on Friday, May 8th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). Cresco Labs had a negative net margin of 20.90% and a negative return on equity of 17.98%. The firm had revenue of $151.32 million for the quarter, compared to analyst estimates of $148.58 million. On average, analysts expect Cresco Labs to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Cresco Labs Stock Performance

Cresco Labs stock opened at $0.64 on Thursday. Cresco Labs has a 12-month low of $0.54 and a 12-month high of $2.30. The company has a market capitalization of $322.57 million, a price-to-earnings ratio of -1.65 and a beta of 1.52. The company has a debt-to-equity ratio of 1.78, a current ratio of 2.51 and a quick ratio of 1.41. The firm’s fifty day moving average price is $0.81 and its 200 day moving average price is $0.95.

Cresco Labs Company Profile

Cresco Labs is a vertically integrated, multi-state cannabis operator in the United States. The company engages in the cultivation, manufacturing and distribution of a broad range of cannabis products, including flower, pre-rolled joints, concentrates, vaporizers, edibles and tinctures. Cresco Labs’ operations span cultivation facilities, processing laboratories and a network of wholesale distribution centers that supply licensed dispensaries and retail outlets across key cannabis markets.

The company’s product portfolio is organized under several branded platforms, such as MÜV, Reserve and High Supply, each designed to address different segments of the adult-use and medical cannabis markets.